Risk of tuberculosis is higher with anti–tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three‐year prospective french research axed on tolerance of biotherapies registry
作者： F. Tubach , D. Salmon , P. Ravaud , Y. Allanore , P. Goupille
DOI: 10.1002/ART.24632
关键词:
摘要: Background Tuberculosis (TB) is associated with anti-tumour necrosis factor (TNF) therapy but whether it drug-specific remains a concern. Our objective was to describe cases of tuberculosis anti-TNF therapy, identify risk factors and estimate the incidence.
cabdirect.org
archives-ouvertes.fr
sci-hub.se 参考文章(29)
Johan Askling, C. Michael Fored, Lena Brandt, Eva Baecklund, Lennart Bertilsson, Lars Cöster, Pierre Geborek, Lennart T. Jacobsson, Staffan Lindblad, Jörgen Lysholm, Solbritt Rantapää-Dahlqvist, Tore Saxne, Victoria Romanus, Lars Klareskog, Nils Feltelius, Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden. Arthritis & Rheumatism. ,vol. 52, pp. 1986- 1992 ,(2005) , 10.1002/ART.21137
Fraser R Imrie, Andrew D Dick, Biologics in the treatment of uveitis. Current Opinion in Ophthalmology. ,vol. 18, pp. 481- 486 ,(2007) , 10.1097/ICU.0B013E3282F03D42
Hillarie L. Plessner, P. Ling Lin, Tadahiko Kohno, James S. Louie, Denise Kirschner, John Chan, JoAnne L. Flynn, Neutralization of Tumor Necrosis Factor (TNF) by Antibody but not TNF Receptor Fusion Molecule Exacerbates Chronic Murine Tuberculosis The Journal of Infectious Diseases. ,vol. 195, pp. 1643- 1650 ,(2007) , 10.1086/517519
Joseph Keane, Sharon Gershon, Robert P. Wise, Elizabeth Mirabile-Levens, John Kasznica, William D. Schwieterman, Jeffrey N. Siegel, M. Miles Braun, Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent The New England Journal of Medicine. ,vol. 345, pp. 1098- 1104 ,(2001) , 10.1056/NEJMOA011110
Anca Irinel Catrina, Christina Trollmo, Erik af Klint, Marianne Engstrom, Jon Lampa, Ylva Hermansson, Lars Klareskog, Ann Kristin Ulfgren, Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report. Arthritis & Rheumatism. ,vol. 52, pp. 61- 72 ,(2005) , 10.1002/ART.20764
A. J. Silman, D. P. M. Symmons, , , W. G. Dixon, K. Watson, M. Lunt, K. L. Hyrich, Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. Arthritis & Rheumatism. ,vol. 54, pp. 2368- 2376 ,(2006) , 10.1002/ART.21978
X Mariette, D Salmon, French guidelines for diagnosis and treating latent and active tuberculosis in patients with RA treated with TNF blockers Annals of the Rheumatic Diseases. ,vol. 62, pp. 791- 791 ,(2003) , 10.1136/ARD.62.8.791
R. S. Wallis, M. Broder, J. Wong, D. Beenhouwer, Granulomatous Infections Due to Tumor Necrosis Factor Blockade: Correction Clinical Infectious Diseases. ,vol. 39, pp. 1254- 1255 ,(2004) , 10.1086/424455
Frederick Wolfe, Kaleb Michaud, Janice Anderson, Kathy Urbansky, Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy Arthritis & Rheumatism. ,vol. 50, pp. 372- 379 ,(2004) , 10.1002/ART.20009
Jan M.H Van den Brande, Henri Braat, Gijs R van den Brink, Henri H Versteeg, Christiaan A Bauer, Inge Hoedemaeker, Catherine van Montfrans, Daan W Hommes, Maikel P Peppelenbosch, Sander J.H van Deventer, Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn’s disease Gastroenterology. ,vol. 124, pp. 1774- 1785 ,(2003) , 10.1016/S0016-5085(03)00382-2